Pharmaceuticals
CSL to acquire Novartis’ influenza vaccine unit
27 Oct 2014
Pfizer's $11-bn share repurchase ends chances of renewed bid for AstraZeneca
25 Oct 2014
US drugmaker Pfizer’s board yesterday authorised a new $11-billion share repurchase plan, which analysts say puts an end to speculations that it would renew its bid for British rival AstraZeneca
AbbVie calls off $55-bn acquisition of Shire over US tax rules
22 Oct 2014
AbbVie said the new US tax rules would keep it from gaining access to its overseas cash without having to pay hefty US taxes
Pfizer’s anti-smoking drug Chantix to carry black-box waning till availability of study data
17 Oct 2014
AbbVie to reconsider $55-bn Shire deal
15 Oct 2014
AbbVie, the maker of top-selling arthritis drug Humira, plans to buy Shire to lower its US tax burden by moving its tax base to Ireland and to diversify its product line-up
